p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx. 2007

Federica Perrone, and Luigi Mariani, and Elisa Pastore, and Marta Orsenigo, and Simona Suardi, and Barbara Marcomini, and Luca DaRiva, and Lisa Licitra, and Antonino Carbone, and Marco A Pierotti, and Silvana Pilotti
Unit of Experimental Molecular Pathology, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy. federica.perrone@istitutotumori.mi.it

BACKGROUND Tobacco smoking, alcohol abuse, and high-risk human papillomavirus (HPV) are risk factors in the etiology of oropharyngeal squamous cell carcinomas (SCCs). The TP53 polymorphism, in which an arginine (R) is changed to proline (P) at codon 72, is functionally significant and could therefore be a predisposing genetic defect. METHODS The aim of the study was to investigate the role of codon 72 polymorphism by means of double gradient-denaturing gel electrophoresis in 77 oropharyngeal SCC patients including 33 TP53 mutated and 16 HPV-16-positive cases. The controls consisted of 141 consecutive healthy blood donors. RESULTS The cases and controls showed significantly different genotype distribution (P = .0005): the frequencies of the RR, RP, and PP genotypes among the cases were, respectively, 81.8%, 10.4%, and 7.8%, as opposed to 59.6%, 33.3%, and 7.1% among the controls, in agreement with the Hardy-Weinberg equilibrium (P = .35). The PP genotype was significantly overrepresented among females (22.2% vs 3.4%; P = .0243) and in HPV-16-positive cases (25.0% vs 3.3%; P = .0152). No segregation was found between either of the codon 72 genotypes and age or TP53 mutations. CONCLUSIONS The significantly lower frequency of the RP genotype in the patients as a whole suggests that it has a protective effect on oropharyngeal SCCs. Moreover, the PP genotype may be a risk factor for the development of oropharyngeal SCC by females and the development of HPV-16-related SCC, although the findings need to be validated in a larger number of tumors.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009856 Oncogene Proteins, Viral Products of viral oncogenes, most commonly retroviral oncogenes. They usually have transforming and often protein kinase activities. Viral Oncogene Proteins,Viral Transforming Proteins,v-onc Proteins,Transforming Proteins, Viral,v onc Proteins
D009959 Oropharyngeal Neoplasms Tumors or cancer of the OROPHARYNX. Cancer of Oropharnyx,Oropharyngeal Cancer,Cancer of the Oropharynx,Neoplasms, Oropharyngeal,Oropharynx Cancer,Oropharynx Neoplasms,Cancer, Oropharyngeal,Cancer, Oropharynx,Cancers, Oropharyngeal,Cancers, Oropharynx,Neoplasm, Oropharyngeal,Neoplasm, Oropharynx,Neoplasms, Oropharynx,Oropharnyx Cancer,Oropharnyx Cancers,Oropharyngeal Cancers,Oropharyngeal Neoplasm,Oropharynx Cancers,Oropharynx Neoplasm
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D003062 Codon A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). Codon, Sense,Sense Codon,Codons,Codons, Sense,Sense Codons
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females

Related Publications

Federica Perrone, and Luigi Mariani, and Elisa Pastore, and Marta Orsenigo, and Simona Suardi, and Barbara Marcomini, and Luca DaRiva, and Lisa Licitra, and Antonino Carbone, and Marco A Pierotti, and Silvana Pilotti
December 2000, Cancer research,
Federica Perrone, and Luigi Mariani, and Elisa Pastore, and Marta Orsenigo, and Simona Suardi, and Barbara Marcomini, and Luca DaRiva, and Lisa Licitra, and Antonino Carbone, and Marco A Pierotti, and Silvana Pilotti
April 2008, Carcinogenesis,
Federica Perrone, and Luigi Mariani, and Elisa Pastore, and Marta Orsenigo, and Simona Suardi, and Barbara Marcomini, and Luca DaRiva, and Lisa Licitra, and Antonino Carbone, and Marco A Pierotti, and Silvana Pilotti
March 2009, Oncology reports,
Federica Perrone, and Luigi Mariani, and Elisa Pastore, and Marta Orsenigo, and Simona Suardi, and Barbara Marcomini, and Luca DaRiva, and Lisa Licitra, and Antonino Carbone, and Marco A Pierotti, and Silvana Pilotti
November 2021, Investigative ophthalmology & visual science,
Federica Perrone, and Luigi Mariani, and Elisa Pastore, and Marta Orsenigo, and Simona Suardi, and Barbara Marcomini, and Luca DaRiva, and Lisa Licitra, and Antonino Carbone, and Marco A Pierotti, and Silvana Pilotti
April 1999, The American journal of pathology,
Federica Perrone, and Luigi Mariani, and Elisa Pastore, and Marta Orsenigo, and Simona Suardi, and Barbara Marcomini, and Luca DaRiva, and Lisa Licitra, and Antonino Carbone, and Marco A Pierotti, and Silvana Pilotti
August 1999, International journal of cancer,
Federica Perrone, and Luigi Mariani, and Elisa Pastore, and Marta Orsenigo, and Simona Suardi, and Barbara Marcomini, and Luca DaRiva, and Lisa Licitra, and Antonino Carbone, and Marco A Pierotti, and Silvana Pilotti
December 2002, Cancer,
Federica Perrone, and Luigi Mariani, and Elisa Pastore, and Marta Orsenigo, and Simona Suardi, and Barbara Marcomini, and Luca DaRiva, and Lisa Licitra, and Antonino Carbone, and Marco A Pierotti, and Silvana Pilotti
November 2003, Journal of the National Cancer Institute,
Federica Perrone, and Luigi Mariani, and Elisa Pastore, and Marta Orsenigo, and Simona Suardi, and Barbara Marcomini, and Luca DaRiva, and Lisa Licitra, and Antonino Carbone, and Marco A Pierotti, and Silvana Pilotti
April 2012, Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale,
Federica Perrone, and Luigi Mariani, and Elisa Pastore, and Marta Orsenigo, and Simona Suardi, and Barbara Marcomini, and Luca DaRiva, and Lisa Licitra, and Antonino Carbone, and Marco A Pierotti, and Silvana Pilotti
July 1991, Oncogene,
Copied contents to your clipboard!